Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Leigh C. Gomez Dahl"'
Autor:
Gary A. Croghan, Richard D. Hurt, Ivana T. Croghan, Troy D. Wolter, Lowell C. Dale, Thomas P. Moyer, Leigh C. Gomez-Dahl, Kenneth P. Offord
Publikováno v:
Psychopharmacology. 140:98-104
Nicotine nasal spray and nicotine gum have been found to be effective in relieving nicotine withdrawal symptoms. In this randomized single-blind study, 91 cigarette smokers were randomly assigned to a single 1 mg dose of active nicotine nasal spray (
Autor:
Darrell R. Schroeder, Richard D. Hurt, Silke Schmidt, Roger W. Evans, Leigh C. Gomez-Dahl, Christi A. Patten, Kenneth P. Offord, Ivana T. Croghan
Publikováno v:
Mayo Clinic Proceedings. 72:917-924
Objective To estimate the cost-effectiveness of treating nicotine dependence, expressed as cost per net year of life gained by smoking cessation. Design A cost-effectiveness analysis was conducted of a cohort of consecutive adult patients treated for
Autor:
Kenneth P. Offord, Leigh C. Gomez-Dahl, Richard D. Hurt, Thomas R. Gauvin, Roy F. House, Robert C. Colligan, Ivana T. Croghan, Todd A. Smith
Publikováno v:
Pediatrics. 98:659-667
Objective. To evaluate the safety, tolerance, and efficacy of 24-hour nicotine patch therapy in adolescent smokers who were trying to stop smoking. Design. Nonrandomized, open-label, 6-month clinical trial. Setting. Five public high schools in the Ro
Autor:
Gary G. Lauger, Paul A. Fredrickson, Leigh C. Gomez-Dahl, L Wingender, Kenneth P. Offord, G M Lee, Richard D. Hurt, Ivana T. Croghan
Publikováno v:
Psychopharmacology. 122:215-222
Transdermal nicotine has been shown to relieve nicotine withdrawal and to double smoking cessation rates compared to placebo in clinical trials. A 21 or 22 mg/day dose provides a steady state serum nicotine that is less than obtained from smoking. Li
Autor:
Prema P. Peethambaram, Leigh C. Gomez Dahl, Matthew P. Boente, L. Austin Doyle, John Wright, Viji Shridhar, Crescent R. Isham, Mathew J. Mauer, Andrea K. Kukla, Jennifer D. Tibodeau, Keith C. Bible, William J. Maples, Kalli J. Voll, David L. Groteluschen, Alexander D. Colevas, Jill K. Burton, Jacie L. Maguire, Ann L. Oberg, Charles Erlichman
Publikováno v:
Gynecologic oncology. 127(1)
Based upon promising preclinical and phase 1 trial results, combined flavopiridol and cisplatin therapy was evaluated in patients with ovarian and primary peritoneal cancers.A two cohort phase 2 trial of cisplatin (60 mg/m2 IV) immediately followed b
Autor:
Christi A, Patten, Richard D, Hurt, Kenneth P, Offord, Ivana T, Croghan, Leigh C, Gomez-Dahl, Thomas E, Kottke, Robert M, Morse, L, Joseph Melton
Publikováno v:
The American journal on addictions. 12(1)
This population-based, retrospective cohort study examined the association of tobacco use and diagnosis of a depressive disorder (DD) and suicide attempts (SA) before and after discharge from an inpatient addiction program (IAP). All 813 Olmsted Coun
Autor:
Kenneth P. Offord, Richard D. Hurt, Gary A. Croghan, Leigh C. Gomez-Dahl, Lowell C. Dale, Ivana T. Croghan
Publikováno v:
Mayo Clinic proceedings. 73(2)
To determine the extent of side effects during the initial use of nicotine nasal spray for smoking cessation.We performed a one-sample, noncomparative, open-label evaluation of the pattern of use, side effects, relief of withdrawal symptoms, and coti
Autor:
Kenneth P. Offord, L. Joseph Melton, Ivana T. Croghan, Robert M. Morse, Leigh C. Gomez-Dahl, Thomas E. Kottke, Richard D. Hurt
Publikováno v:
JAMA. 275(14)
To determine the impact of tobacco- and alcohol-related deaths on overall mortality following inpatient treatment for alcoholism and other nonnicotine drugs of dependence.Population-based retrospective cohort study.Olmsted County, Minnesota (the Roch
Autor:
Keith Christopher Bible, Prema P. Peethambaram, Ann L. Oberg, William J. Maples, David L. Groteluschen, Matthew Boente, Jill K. Burton, Leigh C. Gomez-Dahl, Jennifer D. Tibodeau, Crescent R. Isham, Andrea K. Kukla, Kalli J. Voll, Alexander D. Colevas, John Wright, L Austin Doyle, Charles Erlichman, Mayo Phase Consortium
Publikováno v:
Cancer Research. 71:4712-4712
Background: Based upon preclinical synergy and prior phase 1 study results, the clinical efficacy of flavopiridol combined with cisplatin was assessed in patients with recurrent ovarian and primary peritoneal cancers. Methods: A two cohort phase 2 tr